带状疱疹疫苗的中国市场(2022年～2031年)

2020年带状疱疹疫苗进入到中国市场以来，带状疱疹疫苗的年度销售额达到1,900万人民币(285万美元)，年度销售数量达到约1万2,000份。预计2022年～2031年之间市场扩大，销售额持续增加。

本报告提供中国的带状疱疹疫苗市场相关调查分析，COVID-19的影响，市场规模，厂商分析，市场预测等资讯。

第1章 带状疱疹疫苗的相关概念

• 带状疱疹疫苗的适应症
• 中国的带状疱疹疫苗的开发
• 中国的带状疱疹疫苗的政府核准
• COVID-19对中国的带状疱疹疫苗的销售的影响

第2章 中国的带状疱疹疫苗的销售(2020年～2021年)

• 带状疱疹疫苗的销售额
  • 整体销售额
  • 各地区的销售额
• 带状疱疹疫苗的销售数量
  • 整体销售数量
  • 各地区的销售数量
• 中国的带状疱疹疫苗的销售:各投药法(2020年～2021年)
  • 注射
  • 其他投药法的分析

第3章 中国的主要带状疱疹疫苗製造商分析(2020年～2021年)

• 主要的带状疱疹疫苗製造商市场占有率分析
  • 市场占有率调查:各销售额
  • 市场占有率调查:各销售数量
• GlaxoSmithKline Biologicals
  • 企业简介
  • 中国的SHINGRIX(GlaxoSmithKline Biologicals公司的带状疱疹疫苗)的销售

第4章 中国的各种製造商带状疱疹疫苗的价格(2021年～2022年)

• GlaxoSmithKline Biologicals(SHINGRIX)
• 其他

第5章 中国的带状疱疹疫苗市场预测(2022年～2026年)

• 中国的带状疱疹疫苗市场开发的影响因素
  • COVID-19对中国的带状疱疹疫苗市场的影响
  • 推动市场要素和机会
  • 市场威胁与课题
• 市场规模的预测
• 市场趋势的预测

The trade name of shingles vaccine (recombinant zoster vaccine) is SHINGRIX, which was developed by GlaxoSmithKline. Its product was firstly approved in China in 2020. Shingles vaccine is suitable for adults aged 50 years and over to protect against shingles (herpes zoster). The recombinant zoster vaccine has been listed in the Chinese market. By July 2022, GlaxoSmithKline Biologicals is the only manufacturer in the Chinese Shingles Vaccine market.

According to CRI's market research, since Shingles Vaccine entered the Chinese market in 2020, its annual sales value reached CNY19 million(US$2.85 million), and its annual sales volume reached nearly 12,000 doses. Therefore, the development prospects are quite good.

According to CRI analysis, from 2022 to 2031, as Shingles Vaccine market expands, its sales will continue to grow. Compared with Merck's Zostavax, SHINGRIX has better preventive effects and faster replacement velocity. Therefore, as the market share of Shingles Vaccine will gradually increase, and sales and sales volume will also increase.

Topics covered:

• The impact of COVID-19 on China's Shingles Vaccine market

• Sales volume and value of China's Shingles Vaccine 2020-2021

• Sales volume and value of Shingles Vaccine by regions in China 2020-2021

• Competitive landscape of China's Shingles Vaccine market

• Prices of Shingles Vaccine in China

• Prices of Shingles Vaccine in China by regions in China

• Analysis on factors affecting the development of China's Shingles Vaccine market

• Prospect of China's Shingles Vaccine market from 2022 to 2031

Table of Contents

1 Relevant Concepts of Shingles Vaccine

• 1.1 Indications for Shingles Vaccine
• 1.2 Development of Shingles Vaccine in China
• 1.3 Governmental Approval of Shingles Vaccine in China
• 1.4 The Impact of COVID-19 on Shingles Vaccine sales in China

2 Sales of Shingles Vaccine in China in 2020-2021

• 2.1 Sales Value of Shingles Vaccine
  • 2.1.1 Overall Sales Value
  • 2.1.2 Sales Value by Regions
• 2.2 Sales Volume of Shingles Vaccine
  • 2.2.1 Overall Sales Volume
  • 2.2.2 Sales Volume by Regions
• 2.3 Sales of Shingles Vaccine by Dosage Form in China in 2020-2021
  • 2.3.1 Injection
  • 2.3.2 Analysis of Other Dosage Forms

3 Analysis of Major Shingles Vaccine Manufacturers in China in 2020-2021

• 3.1 Analysis of Market Share of Major Shingles Vaccine Manufacturers
  • 3.1.1 Investigation on Market Share by Sales Value
  • 3.1.2 Investigation on Market Share by Sales volume
• 3.2 GlaxoSmithKline Biologicals
  • 3.2.1 Enterprise Profile
  • 3.2.2 Sales of SHINGRIX (GlaxoSmithKline Biologicals' Shingles Vaccine) in China

4 Prices of Shingles Vaccine for Different Manufacturers in China, 2021-2022

• 4.1 GlaxoSmithKline Biologicals (SHINGRIX)
• 4.2 Others

5 Prospect of Chinese Shingles Vaccine Market, 2022-2026

• 5.1 Influential Factors of Chinese Shingles Vaccine Market Development
  • 5.1.1 The Impact of COVID-19 on Chinese Shingles Vaccine Market
  • 5.1.2 Market Drivers and Opportunities
  • 5.1.3 Market Threats and Challenges
• 5.2 Forecast on Market Size
• 5.3 Forecast on Market Trend

List of Charts

• Chart Patent Information About Shingles Vaccine Injection Registration in China
• Chart Sales Value of Shingles Vaccine Injection over the World
• Chart Sales Value of Shingles Vaccine Injection in China in 2020-2021
• Chart Sales Value of Shingles Vaccine Injection in China by Regions in 2020-2021
• Chart Sales Volume of Shingles Vaccine Injection in China in 2020-2021
• Chart Sales Volume of Shingles Vaccine Injection in China by Regions in 2020-2021
• Chart Market Share by Sales Value of Top Shingles Vaccine Manufacturers in China in 2020-2021
• Chart Sales Value and Volume of SHINGRIX in China in 2020-2021
• Chart Referential Prices of SHINGRIX in China by Regions, 2021-2022
• Chart Forecast on Sales Value of Shingles Vaccine in China, 2022-2031
• Chart Forecast on Sales Volume of Shingles Vaccine in China, 2022-2031